Cargando…
Cathelicidins Modulate TLR-Activation and Inflammation
Cathelicidins are short cationic peptides that are part of the innate immune system. At first, these peptides were studied mostly for their direct antimicrobial killing capacity, but nowadays they are more and more appreciated for their immunomodulatory functions. In this review, we will provide a c...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296178/ https://www.ncbi.nlm.nih.gov/pubmed/32582207 http://dx.doi.org/10.3389/fimmu.2020.01137 |
_version_ | 1783546796740444160 |
---|---|
author | Scheenstra, Maaike R. van Harten, Roel M. Veldhuizen, Edwin J. A. Haagsman, Henk P. Coorens, Maarten |
author_facet | Scheenstra, Maaike R. van Harten, Roel M. Veldhuizen, Edwin J. A. Haagsman, Henk P. Coorens, Maarten |
author_sort | Scheenstra, Maaike R. |
collection | PubMed |
description | Cathelicidins are short cationic peptides that are part of the innate immune system. At first, these peptides were studied mostly for their direct antimicrobial killing capacity, but nowadays they are more and more appreciated for their immunomodulatory functions. In this review, we will provide a comprehensive overview of the various effects cathelicidins have on the detection of damage- and microbe-associated molecular patterns, with a special focus on their effects on Toll-like receptor (TLR) activation. We review the available literature based on TLR ligand types, which can roughly be divided into lipidic ligands, such as LPS and lipoproteins, and nucleic-acid ligands, such as RNA and DNA. For both ligand types, we describe how direct cathelicidin-ligand interactions influence TLR activation, by for instance altering ligand stability, cellular uptake and receptor interaction. In addition, we will review the more indirect mechanisms by which cathelicidins affect downstream TLR-signaling. To place all this information in a broader context, we discuss how these cathelicidin-mediated effects can have an impact on how the host responds to infectious organisms as well as how these effects play a role in the exacerbation of inflammation in auto-immune diseases. Finally, we discuss how these immunomodulatory activities can be exploited in vaccine development and cancer therapies. |
format | Online Article Text |
id | pubmed-7296178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72961782020-06-23 Cathelicidins Modulate TLR-Activation and Inflammation Scheenstra, Maaike R. van Harten, Roel M. Veldhuizen, Edwin J. A. Haagsman, Henk P. Coorens, Maarten Front Immunol Immunology Cathelicidins are short cationic peptides that are part of the innate immune system. At first, these peptides were studied mostly for their direct antimicrobial killing capacity, but nowadays they are more and more appreciated for their immunomodulatory functions. In this review, we will provide a comprehensive overview of the various effects cathelicidins have on the detection of damage- and microbe-associated molecular patterns, with a special focus on their effects on Toll-like receptor (TLR) activation. We review the available literature based on TLR ligand types, which can roughly be divided into lipidic ligands, such as LPS and lipoproteins, and nucleic-acid ligands, such as RNA and DNA. For both ligand types, we describe how direct cathelicidin-ligand interactions influence TLR activation, by for instance altering ligand stability, cellular uptake and receptor interaction. In addition, we will review the more indirect mechanisms by which cathelicidins affect downstream TLR-signaling. To place all this information in a broader context, we discuss how these cathelicidin-mediated effects can have an impact on how the host responds to infectious organisms as well as how these effects play a role in the exacerbation of inflammation in auto-immune diseases. Finally, we discuss how these immunomodulatory activities can be exploited in vaccine development and cancer therapies. Frontiers Media S.A. 2020-06-09 /pmc/articles/PMC7296178/ /pubmed/32582207 http://dx.doi.org/10.3389/fimmu.2020.01137 Text en Copyright © 2020 Scheenstra, van Harten, Veldhuizen, Haagsman and Coorens. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Scheenstra, Maaike R. van Harten, Roel M. Veldhuizen, Edwin J. A. Haagsman, Henk P. Coorens, Maarten Cathelicidins Modulate TLR-Activation and Inflammation |
title | Cathelicidins Modulate TLR-Activation and Inflammation |
title_full | Cathelicidins Modulate TLR-Activation and Inflammation |
title_fullStr | Cathelicidins Modulate TLR-Activation and Inflammation |
title_full_unstemmed | Cathelicidins Modulate TLR-Activation and Inflammation |
title_short | Cathelicidins Modulate TLR-Activation and Inflammation |
title_sort | cathelicidins modulate tlr-activation and inflammation |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296178/ https://www.ncbi.nlm.nih.gov/pubmed/32582207 http://dx.doi.org/10.3389/fimmu.2020.01137 |
work_keys_str_mv | AT scheenstramaaiker cathelicidinsmodulatetlractivationandinflammation AT vanhartenroelm cathelicidinsmodulatetlractivationandinflammation AT veldhuizenedwinja cathelicidinsmodulatetlractivationandinflammation AT haagsmanhenkp cathelicidinsmodulatetlractivationandinflammation AT coorensmaarten cathelicidinsmodulatetlractivationandinflammation |